Prevention of rejection with BTI-322 after renal transplantation (results at 9 months)

Transplant Proc. 1997 Aug;29(5):2425-6. doi: 10.1016/s0041-1345(97)00432-6.

Authors

T Besse¹, J Malaise, M Mourad, Y Pirson, J Hope, M Awwad, M White-Scharf, J P Squifflet

Affiliation

¹ Department of Renal and Pancreatic Transplantation, University of Louvain Medical School, Brussels, Belgium.

PMID: 9270793
DOI: 10.1016/s0041-1345(97)00432-6

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antibodies, Monoclonal / therapeutic use*
CD2 Antigens / immunology
Female
Graft Rejection / immunology
Graft Rejection / prevention & control*
Humans
Kidney Transplantation*
Male
Middle Aged

Substances

Antibodies, Monoclonal
CD2 Antigens
LO-CD2a